Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in ChinaLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 22, 2026, FDA's public records list Hisun Pharmaceutical (Hangzhou) with 22 drug applications. The most recent is a drug application dated Jul 23, 2026: Fludarabine Phosphate.
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Jul 23, 2026 | Fludarabine PhosphateANDA 220196 | Drug application |
| Jan 21, 2026 | Micafungin SodiumANDA 219712 | Drug application |
| Apr 21, 2021 | DaptomycinANDA 212250 | Drug application |
| Dec 31, 2020 | OlanzapineANDA 206892 | Drug application |
| Dec 31, 2020 | OlanzapineANDA 206924 | Drug application |
| Nov 25, 2019 | CladribineANDA 210856 | Drug application |
| Jul 16, 2019 | DactinomycinANDA 207232 | Drug application |
| May 13, 2019 | Doxorubicin HydrochlorideANDA 206062 | Drug application |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.